Behrooz Ataei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Behrooz Ataei has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Abdolvahab Moradi
Golestan University of Medical Sciences
1 shared publication- Afagh Moattari
Department of Bacteriology & Virology, Shiraz Medical School, Shiraz University of medical Sciences, Shiraz, Iran
1 shared publication - Ahmad Piroozmand
Autoimmune Diseases Research Center, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
1 shared publication - Ahmed Sayed Abddel-Moneim
Department of Microbiology and Immunology, College of Medicine and Health Sciences Sultan Qaboos University Muscat Oman
1 shared publication - Akram Ezani
Qazvin Deputy of Treatment Reference Laboratory, Qazvin University of Medical Sciences
1 shared publication - Ali Jafarpour
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 10 March 2026
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 33 (1) , 1-3
Psychological and Behavioral Determinants of Vaccine Efficacy: Insights from SARS-CoV-2 and Implications for Future Pandemics
Despite widespread vaccination, SARS-CoV-2 continues to circulate in waves, highlighting the need to better understand the multifactorial determinants of vaccine efficacy. Beyond its immediate health impact, the pandemic has intensified skepticism toward vaccines – a phenomenon with historical precedent dating back to Edward Jenner (1). Current hesitancy often arises from adverse effects, the accelerated pace of vaccine development, competition among pharmaceutical companies, and the proliferation of misinformation. While some concerns are evidence-based, many reflect perceived opacity from developers and political influence, as well as rumors.We hypothesize that negative attitudes toward vaccination may directly compromise immune responses. Psychological stress, anxiety, and depression can alter the neuroimmune axis, reducing both cellular and humoral immunity. This may partly explain suboptimal vaccine responses during COVID-19 and could influence outcomes in future pandemics.
- 10 March 2026
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 33 (1) , 1-3
Open AccessPsychological and Behavioral Determinants of Vaccine Efficacy: Insights from SARS-CoV-2 and Implications for Future Pandemics
Despite widespread vaccination, SARS-CoV-2 continues to circulate in waves, highlighting the need to better understand the multifactorial determinants of vaccine efficacy. Beyond its immediate health impact, the pandemic has intensified skepticism toward vaccines – a phenomenon with historical precedent dating back to Edward Jenner (1). Current hesitancy often arises from adverse effects, the accelerated pace of vaccine development, competition among pharmaceutical companies, and the proliferation of misinformation. While some concerns are evidence-based, many reflect perceived opacity from developers and political influence, as well as rumors.We hypothesize that negative attitudes toward vaccination may directly compromise immune responses. Psychological stress, anxiety, and depression can alter the neuroimmune axis, reducing both cellular and humoral immunity. This may partly explain suboptimal vaccine responses during COVID-19 and could influence outcomes in future pandemics.
- Open Access
- 30 June 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (2) , 68-73
Effects of Oral Probiotic Supplements on the Rate of Vaginal Colonization of Group B Streptococcus in Pregnant Women: A Clinical Trial Study
Background: Management of Group B Streptococcus (GBS) infection in a pregnant woman is one of the serious challenges for gynecologists and infectious disease specialists. The present clinical trial study aimed to investigate the impact of oral probiotic supplements on the rate of vaginal colonization of GBS in pregnant women. Methods: Overall, 64 pregnant patients with vaginal GBS were selected to participate in this study. They were randomly divided into two groups (n=32/each). The intervention group received a probiotic supplement capsule at a dose of 500 mg daily for 30 days, and the control group received a placebo for 30 days. At the end of the study on day 30, the vaginal sample was retaken with a sterile swab, and all the steps performed at the beginning of the study to diagnose GBS were repeated. Results: The average mean gestation at the first vaginal sampling was 27.09±2.48 weeks. There was no meaningful difference in age between the two groups of patients (P=0.47). Moreover, no considerable difference was found in the body mass index (P=0.37), weeks of gestation (P=0.92), or number of pregnancies (P=0.89) between the two groups. A significant relationship was observed between positive GBS and BMI in pregnant women (P=0.001), but this meaningful relationship was not found between GBS and age of patients (P=0.86) and age of pregnancy (P=0.16). Finally, there was no significant difference between the probiotic and placebo groups in terms of secondary test results for GBS (P=0.07). Conclusion: In the present study, oral probiotic supplementation did not significantly alter GBS in pregnant women, but for a definite opinion, a study with a larger sample size, different vaginal sampling techniques, a higher dose of oral probiotics, and an increase in the length of the intervention period is essential.
- 30 June 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Clinical Microbiology and Infection
- Vol. 11 (2) , 68-73
Open AccessEffects of Oral Probiotic Supplements on the Rate of Vaginal Colonization of Group B Streptococcus in Pregnant Women: A Clinical Trial Study
Background: Management of Group B Streptococcus (GBS) infection in a pregnant woman is one of the serious challenges for gynecologists and infectious disease specialists. The present clinical trial study aimed to investigate the impact of oral probiotic supplements on the rate of vaginal colonization of GBS in pregnant women. Methods: Overall, 64 pregnant patients with vaginal GBS were selected to participate in this study. They were randomly divided into two groups (n=32/each). The intervention group received a probiotic supplement capsule at a dose of 500 mg daily for 30 days, and the control group received a placebo for 30 days. At the end of the study on day 30, the vaginal sample was retaken with a sterile swab, and all the steps performed at the beginning of the study to diagnose GBS were repeated. Results: The average mean gestation at the first vaginal sampling was 27.09±2.48 weeks. There was no meaningful difference in age between the two groups of patients (P=0.47). Moreover, no considerable difference was found in the body mass index (P=0.37), weeks of gestation (P=0.92), or number of pregnancies (P=0.89) between the two groups. A significant relationship was observed between positive GBS and BMI in pregnant women (P=0.001), but this meaningful relationship was not found between GBS and age of patients (P=0.86) and age of pregnancy (P=0.16). Finally, there was no significant difference between the probiotic and placebo groups in terms of secondary test results for GBS (P=0.07). Conclusion: In the present study, oral probiotic supplementation did not significantly alter GBS in pregnant women, but for a definite opinion, a study with a larger sample size, different vaginal sampling techniques, a higher dose of oral probiotics, and an increase in the length of the intervention period is essential.
- Open Access
- 1 January 2022
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 54 (3) , 206-212
Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
Objective: There is no conclusive evidence to suggest vitamin D level can prevent or treat infection with the new coronavirus disease 2019. This study aimed to investigate the effects of serum level of vitamin D in patients with coronavirus disease 2019 on death, severity, and hospitalization duration. Materials and Methods: Baseline characteristic of patients was extracted from the Isfahan coronavirus disease 2019 registry database (I-CORE). Blood samples were taken from all patients to measure the level of vitamin D (25-hydroxyvitamin D) and categorized. The effect of 25(OH) D on death, severity, and hospitalization duration was analyzed by logistic regression. Results: Among our study patients, 5.5% had a severe deficiency of vitamin D, 23.7% deficiency, and 24.8% insufficiency. Of the 107 patients who died, 7.5% were severely deficient in vitamin D. We found that vitamin D deficiency had no significant effect on death, disease severity, and hospitalization (P > .05). However, having at least one comorbidity increased the odds of death five times after adjusting age > 60 years and gender (P < .0001). The results showed that among all comorbidities, diabetes has the greatest impact on the outcomes as it raised the odds of death, disease severity, and length of hospital stay by 2.23,1.72, and 1.48, respectively, after controlling the age > 60 and gender (P = .0002, P=.08, P=.012). Conclusions: The mortality, disease severity, and hospitalization of coronavirus disease 2019 patients seem to be not affected by the low levels of 25(OH)D. However, the synergy between vitamin D levels and comorbidities, age, and gender could affect the outcome of coronavirus disease 2019 patients. Cite this article as: Dana N, Nasirian M, Vaseghi G, et al. Vitamin D level in laboratory confirmed COVID-19 and disease progression. Eurasian J Med., 2022;54(3):206-212.
- 1 January 2022
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 54 (3) , 206-212
Open AccessVitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
Objective: There is no conclusive evidence to suggest vitamin D level can prevent or treat infection with the new coronavirus disease 2019. This study aimed to investigate the effects of serum level of vitamin D in patients with coronavirus disease 2019 on death, severity, and hospitalization duration. Materials and Methods: Baseline characteristic of patients was extracted from the Isfahan coronavirus disease 2019 registry database (I-CORE). Blood samples were taken from all patients to measure the level of vitamin D (25-hydroxyvitamin D) and categorized. The effect of 25(OH) D on death, severity, and hospitalization duration was analyzed by logistic regression. Results: Among our study patients, 5.5% had a severe deficiency of vitamin D, 23.7% deficiency, and 24.8% insufficiency. Of the 107 patients who died, 7.5% were severely deficient in vitamin D. We found that vitamin D deficiency had no significant effect on death, disease severity, and hospitalization (P > .05). However, having at least one comorbidity increased the odds of death five times after adjusting age > 60 years and gender (P < .0001). The results showed that among all comorbidities, diabetes has the greatest impact on the outcomes as it raised the odds of death, disease severity, and length of hospital stay by 2.23,1.72, and 1.48, respectively, after controlling the age > 60 and gender (P = .0002, P=.08, P=.012). Conclusions: The mortality, disease severity, and hospitalization of coronavirus disease 2019 patients seem to be not affected by the low levels of 25(OH)D. However, the synergy between vitamin D levels and comorbidities, age, and gender could affect the outcome of coronavirus disease 2019 patients. Cite this article as: Dana N, Nasirian M, Vaseghi G, et al. Vitamin D level in laboratory confirmed COVID-19 and disease progression. Eurasian J Med., 2022;54(3):206-212.
- Open Access
Disease waves of SARS-CoV-2 in Iran closely mirror global pandemic trends
SARS-CoV-2 genome surveillance projects provide a good measure of transmission and monitor the circulating SARS-CoV-2 variants at regional and global scales. Iran is one of the most affected countries still involved with the virus circulating in at least five significant disease waves, as of September 2021. Complete genome sequencing of 50 viral isolates in an early phase of outbreak in Iran, shed light on the origins and circulating lineages at that time. As part of a genomic surveillance program, we provided an additional 319 complete genomes from October 2020 onwards. The current study is the report of complete SARS-CoV-2 genome sequences of Iran in the March 2020-May 2021 time interval. We aimed to characterize the genetic diversity of SARS-CoV-2 in Iran over one year. Overall, 35 different lineages and 8 clades were detected. Temporal dynamics of the prominent SARS-CoV-2 clades/lineages circulating in Iran is comparable to the global perspective and introduces the 19A clade (B.4) dominating the first disease wave, followed by 20A (B.1.36), 20B (B.1.1.413), 20I (B.1.1.7) clades, dominating second, third and fourth disease waves, respectively. We observed a mixture of circulating 20A (B.1.36), 20B (B.1.1.413), 20I (B.1.1.7) clades in winter 2021, paralleled in a diminishing manner for 20A/20B and a growing rise for 20I, eventually prompting the 4 th outbreak peak. Furthermore, our study provides evidence on the entry of the Delta variant in April 2021, leading to the 5 th disease wave in summer 2021. Three lineages are highlighted as hallmarks of SARS-CoV-2 outbreak in Iran; B4, dominating early periods of the epidemic, B.1.1.413 (specific B.1.1 lineage carrying a combination of [D138Y-S477N-D614G] spike mutations) in October 2020-February 2021, and the co-occurrence of [I100T-L699I] spike mutations in half of B.1.1.7 sequences mediating the fourth peak. Continuous monthly monitoring of SARS-CoV-2 genome mutations led to the detection of 1577 distinct nucleotide mutations, in which the top recurrent mutations were D614G, P323L, R203K/G204R, 3037C>T, and 241C>T; the renowned combination of mutations in G and GH clades. The most frequent spike mutation is D614G followed by 13 other frequent mutations based on the prominent circulating lineages; B.1.1.7 (H69_V70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H, I100T, and L699I), B.1.1.413 (D138Y, S477N) and B.1.36 (I210del). In brief, mutation surveillance in this study provided a real-time comprehensive picture of the SARS-CoV-2 mutation profile in Iran, which is beneficial for evaluating the magnitude of the epidemic and assessment of vaccine and therapeutic efficiency in this population.
Open AccessDisease waves of SARS-CoV-2 in Iran closely mirror global pandemic trends
SARS-CoV-2 genome surveillance projects provide a good measure of transmission and monitor the circulating SARS-CoV-2 variants at regional and global scales. Iran is one of the most affected countries still involved with the virus circulating in at least five significant disease waves, as of September 2021. Complete genome sequencing of 50 viral isolates in an early phase of outbreak in Iran, shed light on the origins and circulating lineages at that time. As part of a genomic surveillance program, we provided an additional 319 complete genomes from October 2020 onwards. The current study is the report of complete SARS-CoV-2 genome sequences of Iran in the March 2020-May 2021 time interval. We aimed to characterize the genetic diversity of SARS-CoV-2 in Iran over one year. Overall, 35 different lineages and 8 clades were detected. Temporal dynamics of the prominent SARS-CoV-2 clades/lineages circulating in Iran is comparable to the global perspective and introduces the 19A clade (B.4) dominating the first disease wave, followed by 20A (B.1.36), 20B (B.1.1.413), 20I (B.1.1.7) clades, dominating second, third and fourth disease waves, respectively. We observed a mixture of circulating 20A (B.1.36), 20B (B.1.1.413), 20I (B.1.1.7) clades in winter 2021, paralleled in a diminishing manner for 20A/20B and a growing rise for 20I, eventually prompting the 4 th outbreak peak. Furthermore, our study provides evidence on the entry of the Delta variant in April 2021, leading to the 5 th disease wave in summer 2021. Three lineages are highlighted as hallmarks of SARS-CoV-2 outbreak in Iran; B4, dominating early periods of the epidemic, B.1.1.413 (specific B.1.1 lineage carrying a combination of [D138Y-S477N-D614G] spike mutations) in October 2020-February 2021, and the co-occurrence of [I100T-L699I] spike mutations in half of B.1.1.7 sequences mediating the fourth peak. Continuous monthly monitoring of SARS-CoV-2 genome mutations led to the detection of 1577 distinct nucleotide mutations, in which the top recurrent mutations were D614G, P323L, R203K/G204R, 3037C>T, and 241C>T; the renowned combination of mutations in G and GH clades. The most frequent spike mutation is D614G followed by 13 other frequent mutations based on the prominent circulating lineages; B.1.1.7 (H69_V70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H, I100T, and L699I), B.1.1.413 (D138Y, S477N) and B.1.36 (I210del). In brief, mutation surveillance in this study provided a real-time comprehensive picture of the SARS-CoV-2 mutation profile in Iran, which is beneficial for evaluating the magnitude of the epidemic and assessment of vaccine and therapeutic efficiency in this population.
- Open Access
- 10 June 2020
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 49 (1) , 96-103
Species Variety, Antibiotic Susceptibility Patterns and Prevalence of Enterotoxin Genes in Staphylococci Isolated from Foodstuff in Central Iran
Background: The presence and diversity of Staphylococcus species and their enterotoxin-encoding genes in foodstuffs have not been comprehensively studied in some developing countries. This study aimed to assess the frequency of Staphylococcus spp. and their related virulence factors in foodstuffs in Isfahan, Iran. Methods: Overall, 139 foodstuff samples, collected from Isfahan City (center of Iran) from Sep 2015 to Oct 2016, were processed for the presence of Staphylococcus spp. using standard bacteriological procedures and sequence analysis of 16S rRNA gene. Antimicrobial susceptibilities and prevalence of mecA and toxin-encoded genes (sea, seb, sed, see and tsst1) were tested for all of the Staphylococcal isolates. Results: Forty-four Gram-positive cocci were recovered from 139 dairy and meat samples. The most prevalent species were S. vitulinus 25.0% (11/44) and S. aureus 20.5% (9/44); respectively. The most prevalent antimicrobial resistance was noted towards penicillin, cefoxitin and tetracycline. The sec, sea, see and tsst1 genes were found in 19%, 9.5%, 3.5%, and 3.5% of the isolates, respectively. Conclusion: Numerous virulence factors were detected in different Staphylococcus spp. isolated from foodstuffs, more attention should be paid to the presence of the bacteria. Proper hygienic and management practices should be considered in order to increase food safety and prevent extra treatment costs.
- 10 June 2020
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 49 (1) , 96-103
Open AccessSpecies Variety, Antibiotic Susceptibility Patterns and Prevalence of Enterotoxin Genes in Staphylococci Isolated from Foodstuff in Central Iran
Background: The presence and diversity of Staphylococcus species and their enterotoxin-encoding genes in foodstuffs have not been comprehensively studied in some developing countries. This study aimed to assess the frequency of Staphylococcus spp. and their related virulence factors in foodstuffs in Isfahan, Iran. Methods: Overall, 139 foodstuff samples, collected from Isfahan City (center of Iran) from Sep 2015 to Oct 2016, were processed for the presence of Staphylococcus spp. using standard bacteriological procedures and sequence analysis of 16S rRNA gene. Antimicrobial susceptibilities and prevalence of mecA and toxin-encoded genes (sea, seb, sed, see and tsst1) were tested for all of the Staphylococcal isolates. Results: Forty-four Gram-positive cocci were recovered from 139 dairy and meat samples. The most prevalent species were S. vitulinus 25.0% (11/44) and S. aureus 20.5% (9/44); respectively. The most prevalent antimicrobial resistance was noted towards penicillin, cefoxitin and tetracycline. The sec, sea, see and tsst1 genes were found in 19%, 9.5%, 3.5%, and 3.5% of the isolates, respectively. Conclusion: Numerous virulence factors were detected in different Staphylococcus spp. isolated from foodstuffs, more attention should be paid to the presence of the bacteria. Proper hygienic and management practices should be considered in order to increase food safety and prevent extra treatment costs.